“…Notably, involvement of MMP‐9 in degradation of perineuronal nets has been well documented in both animal models and human patients (Alaiyed, Bozzelli, Caccavano, Wu, & Conant, 2019; Alaiyed & Conant, 2019; Brunswick et al, 2002; Gray, Thomas, Betmouni, Scolding, & Love, 2008; Lorenzo Bozzelli, Alaiyed, Kim, Villapol, & Conant, 2018; Murase, Lantz, & Quinlan, 2017; Pollock, Everest, Brown, & Poulter, 2014; Wen, Binder, Ethell, & Razak, 2018). The perineuronal nets preferentially surround inhibitory neurons (Härtig, Brückner, Brauer, Schmidt, & Bigl, 1995; Morris & Henderson, 2000; Naegele, Arimatsu, Schwartz, & Barnstable, 1988; Naegele & Katz, 1990; Seeger, Brauer, Härtig, & Brückner, 1994), such as those expressing PV and calbindin (CALB) (Lensjø, Christensen, Tennøe, Fyhn, & Hafting, 2017; McDonald, Hamilton, & Barnstable, 2018; Ohira, Takeuchi, Iwanaga, & Miyakawa, 2013; Vidal et al, 2006). The disruption of the interplay between the perineuronal nets surrounding these cells and MMP‐9 is thought to contribute to numerous neuropsychiatric and neurodegenerative disorders, including schizophrenia, Alzheimer's disease and epilepsy (Wen, Binder, Ethell, & Razak, 2018).…”